Insider Buy/Sell Details for the Healthcare Sector — Last 7 Days
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (21)
Nano-X Imaging Ltd. (NNOX)
Meltzer Erez — Director
Shares
25,000
Price
$0.45
Total Value
$11.25K
Shares Held After
90,443
% of Holdings
27.6%
X4 Pharmaceuticals, Inc (XFOR)
Craig Adam R — Director
Shares
4,600
Price
$2.58
Total Value
$11.88K
Shares Held After
333,251
% of Holdings
1.4%
Grace Therapeutics, Inc. (GRCE)
Opaleye Management Inc. — 10% Owner
Shares
36,347
Price
$1.89
Total Value
$68.76K
Shares Held After
2,944,354
% of Holdings
1.2%
CTT PHARMACEUTICAL HOLDINGS, INC. (CTTH)
CTT PHARMACEUTICAL HOLDINGS, INC. — Director
Shares
2,000
Price
$0.06
Total Value
$114.00
Shares Held After
9,436,656
% of Holdings
0.0%
HEALTHEQUITY, INC. (HQY)
Rajasekar Sunil — EVP Chief Prod&Strat Officer
Shares
108
Price
$90.33
Total Value
$9.76K
Shares Held After
53,405
% of Holdings
0.2%
Grace Therapeutics, Inc. (GRCE)
Opaleye Management Inc. — 10% Owner
Shares
23,485
Price
$1.95
Total Value
$45.69K
Shares Held After
2,908,007
% of Holdings
0.8%
QTREX Quantum Ltd. (QTEX)
Parnes Tal — Director
Shares
6,666
Price
$1.50
Total Value
$10.00K
Shares Held After
766,666
% of Holdings
0.9%
InMed Pharmaceuticals Inc. (INM)
ADAR1 Capital Management, LLC — 10% Owner
Shares
984
Price
$1.32
Total Value
$1.30K
Shares Held After
955,493
% of Holdings
0.1%
Grace Therapeutics, Inc. (GRCE)
Opaleye Management Inc. — 10% Owner
Shares
11,233
Price
$1.93
Total Value
$21.73K
Shares Held After
2,884,522
% of Holdings
0.4%
Inhibrx Biosciences, Inc. (INBX)
Lappe Mark — Director
Shares
100
Price
$85.76
Total Value
$8.58K
Shares Held After
170,000
% of Holdings
0.1%
Inhibrx Biosciences, Inc. (INBX)
Lappe Mark — Director
Shares
2,451
Price
$85.00
Total Value
$208.33K
Shares Held After
169,900
% of Holdings
1.4%
Inhibrx Biosciences, Inc. (INBX)
Lappe Mark — Director
Shares
2,449
Price
$84.07
Total Value
$205.89K
Shares Held After
167,449
% of Holdings
1.5%
Inhibrx Biosciences, Inc. (INBX)
Lappe Mark — Director
Shares
100
Price
$85.76
Total Value
$8.58K
Shares Held After
745,588
% of Holdings
0.0%
Inhibrx Biosciences, Inc. (INBX)
Lappe Mark — Director
Shares
2,470
Price
$85.00
Total Value
$209.95K
Shares Held After
745,488
% of Holdings
0.3%
Inhibrx Biosciences, Inc. (INBX)
Lappe Mark — Director
Shares
2,470
Price
$84.07
Total Value
$207.65K
Shares Held After
743,018
% of Holdings
0.3%
PROTHENA CORP PUBLIC LTD CO (PRTA)
SCULLY WILLIAM P — 10% Owner
Shares
10,000
Price
$8.46
Total Value
$84.57K
Shares Held After
1,037,000
% of Holdings
1.0%
InMed Pharmaceuticals Inc. (INM)
ADAR1 Capital Management, LLC — 10% Owner
Shares
8,021
Price
$1.33
Total Value
$10.67K
Shares Held After
954,509
% of Holdings
0.8%
QTREX Quantum Ltd. (QTEX)
Ben-Noon Dagi Shahar — Director
Shares
14,093
Price
$1.49
Total Value
$21.00K
Shares Held After
14,093
% of Holdings
100.0%
Beyond Air, Inc. (XAIR)
Lin Yi-Chien — 10% Owner
Shares
2,607
Price
$2.21
Total Value
$5.76K
Shares Held After
148,000
% of Holdings
1.8%
PROTHENA CORP PUBLIC LTD CO (PRTA)
SCULLY WILLIAM P — 10% Owner
Shares
100,000
Price
$8.35
Total Value
$835.48K
Shares Held After
1,027,000
% of Holdings
9.7%
InMed Pharmaceuticals Inc. (INM)
ADAR1 Capital Management, LLC — 10% Owner
Shares
564
Price
$1.33
Total Value
$750.12
Shares Held After
946,488
% of Holdings
0.1%
21 transactions